top of page
Our Capabilities: Video

We offer in vivo PK/PD studies as part of our suite of services to help our clients develop effective therapies for retinal diseases.

Subcutaneous          Intraperitoneal

Intravenous            Intravitreal

Subretinal              Subconjunctival

Suprachoroidal      Oral gavage

Oral syringe           Food/water

In vivo PK/PD studies are critical in assessing the safety and efficacy of a drug candidate before clinical trials can begin. Our highly skilled scientists conduct the therapeutic delivery and sampling themselves, ensuring that your research is in good hands. We use trusted external partners to analyze the samples and provide you with the highest quality data.

At MediNect Bioservices, we are constantly pushing the boundaries of what is possible in retinal disease research. We are currently validating mass spectrometer analysis on cryosections of eyes to identify where in the eye the drug is located. This cutting-edge technology allows us to better understand the pharmacokinetics and pharmacodynamics of your drug candidate and to optimize your research plan accordingly.

Whether you are developing a new drug candidate or refining an existing therapy, our team at MediNect Bioservices can help you navigate the complex world of retinal disease research. Our in vivo PK/PD studies are just one of the many ways we can assist you in achieving your research goals.

 

Contact us today to learn more about our services and how we can help you advance your research.

Our Capabilities: Press Kit
Our Capabilities: Price Quote

Book in a free consultation

Thanks for submitting!

bottom of page